In this issue:
Apixaban for preventing VTE after gynaecological malignancy surgery
Rivaroxaban in deferred workup of suspected DVT
Thromboprophylaxis with dose-adjusted enoxaparin in hospitalised cancer patients
Rivaroxaban in PAD after revascularisation
Rivaroxaban vs. enoxaparin in nonmajor orthopaedic surgery
Molecular profiling and risk classification of SVT due to MPN
Systematic bone marrow smears in older patients with new ITP
VTE risk models vs. age in acutely ill medical inpatients
Red cell transfusions in outpatients with MDS
Alternate vs. consecutive day iron dosing in iron-deficient anaemia
Please login below to download this issue (PDF)